Xtent Inc. Sets IPO At 4.7 Million Shares, $16-$18 Each

Published: Jan 11, 2007

WASHINGTON, Jan 11 (Reuters) - Xtent Inc., which develops stent systems to treat coronary artery disease, on Thursday set its planned initial public offering at 4.7 million shares for an estimated price of $16 to $18 each.

>>> Discuss This Story

Back to news